Lantus Insulin Cartridge 100IU/ml is used to treat type 1 diabetes in adults and children, as well as type 2 diabetes in adults.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
INSULIN GLARGINE is a modified, long-acting insulin akin to human insulin. It treats diabetes mellitus in individuals aged two and above, ensuring steady blood sugar control. Unlike short-acting insulins, it maintains consistent effects over 24 hours without peaks. This treatment prevents diabetes complications, excluding diabetic ketoacidosis.
INSULIN GLARGINE steadies blood sugar levels throughout the day, dosed based on tests, lifestyle, and prior insulin use. Injection site reactions like lumps or hypoglycemia symptoms, e.g., sweating, and anxiety, can occur but usually resolve naturally. Consult your doctor for persistent effects.
Avoid halting INSULIN GLARGINE without consulting your doctor, as it might cause withdrawal symptoms. It's not suitable for low blood glucose, kidney, liver, or heart issues, or with alcohol/recreational drugs. Combine it with a healthy diet, exercise, and weight maintenance as per your doctor's guidance.
Store INSULIN GLARGINE at 2-8°C in the fridge, not the freezer, as it's a cold chain medicine.
Avoid consumption of alcohol while receiving Lantus Insulin Cartridge 100IU/ml as it can raise or lower your blood sugar levels.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before receiving Lantus Insulin Cartridge 100IU/ml N. Careful control of your diabetes, particularly the prevention of hypoglycemia, is important for the health of the baby. The dose will be adjusted by your doctor.
Inform your doctor if you are breastfeeding before receiving Lantus Insulin Cartridge 100IU/ml as it is not known if it is excreted in breast milk. The dose and diet will be adjusted by your doctor.
Do not drive or use machines while receiving Lantus Insulin Cartridge 100IU/ml as your blood sugar can be low or high and your concentration and ability to react might be affected. Consult your doctor if you have frequent episodes of hypoglycemia.
Lantus Insulin Cartridge 100IU/ml should be used with caution in patients with kidney disease. Your dose will be adjusted depending on your age, body weight, and disease condition. Consult your doctor before receiving Lantus Insulin Cartridge 100IU/ml.
Lantus Insulin Cartridge 100IU/ml should be used with caution in patients with liver disease. Your dose will be adjusted depending on your age, body weight, and disease condition. Consult your doctor before receiving it.
Diabetes (Type 1 diabetes mellitus, Type 2 diabetes mellitus)
Lantus Insulin Cartridge 100IU/ml is a long-acting insulin that offers consistent and continuous sugar control throughout the day. It mimics the action of your body's natural insulin, aiding in the uptake of sugar by muscles and fat cells while reducing sugar production in the liver.
Hypoglycemia, allergic responses, injection site reaction, lipodystrophy, pruritus, and rash are all side effects of Insulin glargine.
Diabetes is a chronic condition that disrupts the body's ability to use insulin effectively, a hormone responsible for regulating blood sugar levels. Elevated blood glucose characterizes diabetes. There are two main types: type 1 and type 2 diabetes. Type 1 diabetes occurs when the pancreas produces insufficient or no insulin. Type 2 diabetes impacts sugar processing in the body. Symptoms include fatigue, frequent urination, excessive thirst, dry mouth, blurred vision, persistent hunger, weight loss, and itchy skin. Diabetes management involves monitoring blood sugar levels and adopting lifestyle changes.
Insulin Glargine is a sterile insulin glargine solution intended for subcutaneous injection. Insulin glargine is a long-acting (up to the 24-hour duration of action) parenteral blood glucose-lowering medication made from recombinant human insulin analogs. Recombinant DNA technology is used to make Insulin Glargine. Insulin glargine's primary role is to regulate glucose metabolism. Insulin and its analogs reduce blood glucose levels by stimulating peripheral glucose absorption, especially in skeletal muscle and fat, and decreasing hepatic glucose synthesis. Insulin promotes protein synthesis while inhibiting lipolysis and proteolysis.
Insulin Glargine maintains a consistent glucose-lowering effect for 24 hours, allowing for once-daily dosing. Its potency is similar to human insulin. Administered subcutaneously once daily, it can be taken at any time but should be consistent. The dosage is tailored to each patient's response, and blood glucose monitoring is vital. For type 1 diabetes, the use of short-acting insulin is recommended. Avoid intravenous administration due to potential severe hypoglycemia.
Starting Insulin Glargine:
Switching to Insulin Glargine:
To use the cartridge:
Injection site:
Injection method:
A variety of medications have an effect on glucose metabolism and may necessitate dosage adjustments.
Insulin and Insulin glargine needs may be reduced by the following substances: Angiotensin-converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, propoxyphene, pentoxifylline, salicylates, and sulfonamide antibiotics are all examples of oral anti-diabetic medications.
Insulin and Insulin glargine needs may be increased by the following substances: Thiazides, glucocorticoids, thyroid hormones, beta-sympathomimetics, growth hormone, and danazol are some of the medications used to treat these conditions. Beta-blockers, clonidine, lithium salts, and alcohol may enhance or diminish insulin's blood-glucose-lowering impact.
In patients who are hypersensitive to insulin glargine or any of its excipients, insulin glargine is not recommended.
Category C pregnancy. During pregnancy, insulin glargine should only be administered if the possible benefit outweighs the danger to the fetus.
It is unknown whether insulin glargine is secreted in human milk during lactation. Because many medications, including human insulin, are excreted in human milk, Insulin glargine should be provided with caution to a breastfeeding mother. Insulin dosage and nutrition may need to be adjusted for lactating women.
Dose adjustment and monitoring: All insulin-treated individuals should have their blood glucose levels checked on a regular basis. Insulin regimens should only be changed with caution and under the guidance of a doctor.
Insulin glargine should never be blended or diluted with any other insulin or solution. Because severe hypoglycemia can occur when given subcutaneously via an insulin pump or intravenously, it is not recommended.
Renal or hepatic impairment: In these circumstances, lowering the Insulin glargine dose may be necessary.
Store at 2° C to 8° C in a refrigerator. Do not freeze. In the case of insulin for recent use need not be refrigerated, try to keep it in a cool place and keep it away from heat and light. The insulin in use can be kept at room temperature for a month.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.